Teijin

Related Content

Teijin and Axcelead's agreement on capital and business alliance

Teijin, J-TEC, Mitsui Fudosan and NCC establish regenerative medicine platform

Teijin Pharma and TransThera form strategic R&D collaboration

Teijin signs agreement to research drugs for frailty in elderly people

Teijin to boost production of high-performance microporous membrane

Licence and co-development agreement signed to develop botulinum toxin in Japan

Somatuline Autogel receives Japanese approval for tumour treatment

Teijin to enter tau-targeting license agreement with Merck

Teijin Pharma elects new President

Teijin Pharma and Amgen to jointly research and develop new therapy for kidney diseases

Teijin gains exclusive rights in Japan to growth hormone deficiency treatment

Teijin opens R&D centre to accelerate material and pharmaceutical development

Teijin Pharma to establish new R&D centre to accelerate integrated pharmaceutical development

Japanese regulator approves osteoporosis jelly